Home>>Signaling Pathways>> Immunology/Inflammation>>6-Deoxypenciclovir

6-Deoxypenciclovir (Synonyms: BRL 42359)

Catalog No.GC49749

An inactive metabolite of famciclovir

Products are for research use only. Not for human use. We do not sell to patients.

6-Deoxypenciclovir Chemical Structure

Cas No.: 104227-86-3

Size Price Stock Qty
1 mg
$76.00
In stock
5 mg
$305.00
In stock
10 mg
$533.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

6-Deoxypenciclovir is an inactive metabolite of the antiviral prodrug famciclovir .1,2 It is formed from famciclovir via hydrolysis and is further metabolized via oxidation by aldehyde oxidase to the active metabolite penciclovir . 6-Deoxypenciclovir has been used in the synthesis of prodrug forms of penciclovir.3

1.Rashidi, M.R., Smith, J.A., Clarke, S.E., et al.In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liverDrug Metab. Dispos.25(7)805-813(1997) 2.Groth, A.D., Contreras, M.T., Kado-Fong, H.K., et al.In vitro cytotoxicity and antiviral efficacy against feline herpesvirus type 1 of famciclovir and its metabolitesVet. Ophthalmol.17(4)268-274(2014) 3.Kim, D.K., Lee, N., Ryu, D.H., et al.Synthesis and evaluation of 2-amino-9-(3-acyloxymethyl-4-alkoxycarbonyloxybut-1-yl)purines and 2-amino-9-(3-alkoxycarbonyloxymethyl-4-alkoxycarbonyloxybut-1-yl)purines as potential prodrugs of penciclovirBioorg. Med. Chem.7(8)1715-1725(1999)

Reviews

Review for 6-Deoxypenciclovir

Average Rating: 5 ★★★★★ (Based on Reviews and 4 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 6-Deoxypenciclovir

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.